logo
  

EARNINGS SUMMARY: Details of Biomarin Pharmaceutical Inc. Q2 Earnings Report

Below are the earnings highlights for Biomarin Pharmaceutical Inc. (BMRN):

-Earnings: $12.9 million in Q2 vs. -$29.2 million in the same period last year.
-EPS: $0.07 in Q2 vs. -$0.16 in the same period last year.
-Analysts projected -$0.11 per share
-Revenue: $501.7 million in Q2 vs. $429.5 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT